Nan Huang
Research Subjects
Nan Huang has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Basil J. Nikolau
Iowa State University of Science and Technology, Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, United States
5 shared publications - Diane F. Birt
Iowa State University, Ames, IA
5 shared publications - Ludmila Rizhsky
The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, Iowa, 50011
4 shared publications - Patricia A. Murphy
The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, Iowa, 50011
4 shared publications - Cathy Hauck
The Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, Iowa, 50011
3 shared publications Hao Wang
3 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by Elsevier in SSRN Electronic Journal
Recombinant Type III Humanized Collagen Solution Attenuates Photoaging: Evidence from In Vitro, In Vivo, and Clinical Studies
Objective: The efficacy of RhCol III against structural deterioration and pigmentation disorders in photoaged skin remains unclear. This study used a multimodal translational approach to evaluate its biological effects, safety, and efficacy for facial photoaging.Methods: In vitro, cryo-TEM characterized RhCol III self-assembly with naturally secreted collagen, and a keratinocyte–melanocyte co-culture model assessed effects on UV-induced melanogenesis. In vivo, two-photon microscopy assessed dermal structural changes in real time. In a prospective, single-center, single-arm trial, 43 Chinese women (mean age 38.8 ± 6.26 years; Glogau II–III) received three intradermal RhCol III injections at 4-week intervals. Efficacy was assessed up to 24 weeks using GAIS, Atlas grading, VISIA, and biophysical measurements.Results: RhCol III formed biomimetic fibrils with fibroblast-secreted collagens and attenuated UV-induced melanin accumulation (P < 0.05). Two-photon microscopy revealed restoration of dermal collagen and elastic fibers (all P < 0.01). At 4 weeks post-treatment, 39 (100%) subjects were GAIS responders. Periorbital wrinkles, pigmentation, hydration, and erythema improved significantly (all P < 0.05). Treatment was well-tolerated.Conclusion: Intradermal RhCol III injection is safe and effective for photoaging in periorbital and cheek areas, addressing both structural and pigmentary photodamage.
- 26 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRecombinant Type III Humanized Collagen Solution Attenuates Photoaging: Evidence from In Vitro, In Vivo, and Clinical Studies
Objective: The efficacy of RhCol III against structural deterioration and pigmentation disorders in photoaged skin remains unclear. This study used a multimodal translational approach to evaluate its biological effects, safety, and efficacy for facial photoaging.Methods: In vitro, cryo-TEM characterized RhCol III self-assembly with naturally secreted collagen, and a keratinocyte–melanocyte co-culture model assessed effects on UV-induced melanogenesis. In vivo, two-photon microscopy assessed dermal structural changes in real time. In a prospective, single-center, single-arm trial, 43 Chinese women (mean age 38.8 ± 6.26 years; Glogau II–III) received three intradermal RhCol III injections at 4-week intervals. Efficacy was assessed up to 24 weeks using GAIS, Atlas grading, VISIA, and biophysical measurements.Results: RhCol III formed biomimetic fibrils with fibroblast-secreted collagens and attenuated UV-induced melanin accumulation (P < 0.05). Two-photon microscopy revealed restoration of dermal collagen and elastic fibers (all P < 0.01). At 4 weeks post-treatment, 39 (100%) subjects were GAIS responders. Periorbital wrinkles, pigmentation, hydration, and erythema improved significantly (all P < 0.05). Treatment was well-tolerated.Conclusion: Intradermal RhCol III injection is safe and effective for photoaging in periorbital and cheek areas, addressing both structural and pigmentary photodamage.
- Open Access
- 22 September 2026
- Published by Elsevier in SSRN Electronic Journal
From Nanoparticles to Biomimetic Transform: A pH-Responsive Supramolecular Peptide-AHA for Transdermal Delivery and DEJ & ECM Regeneration
Self-assembling peptides often exhibit poor transdermal delivery despite their bioactivity. Here we exploit the pH-dependent morphology of R2I4R2—nanoparticles at acidic, fibrils at neutral, and films at alkaline pH—and co-assemble it with alpha-hydroxy acids (AHAs) to lock it into skin-permeable nanoparticles, forming supramolecular co-assemblies (SCAs). SCAs enhanced intradermal peptide retention by 5 fold by loosening lipid chain packing without disrupting barrier integrity. Upon penetration, SCAs underwent pH-triggered disassembly-reassembly, forming branched biomimetic topologies. These supramolecular structures enabled whole-cell cytosolic delivery, upregulated proliferation and growth factor signaling, suppressed TRPV1-mediated inflammation, promoted ordered ECM & DEJ regeneration in ex vivo human skin, and reduced erythema while improving barrier function in a 35-subject clinical trial. By integrating dynamic morphological programming with bioactivity, this strategy of morphological transition after supramolecular delivery offers new research directions for the future development of transdermal delivery.
- 22 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFrom Nanoparticles to Biomimetic Transform: A pH-Responsive Supramolecular Peptide-AHA for Transdermal Delivery and DEJ & ECM Regeneration
Self-assembling peptides often exhibit poor transdermal delivery despite their bioactivity. Here we exploit the pH-dependent morphology of R2I4R2—nanoparticles at acidic, fibrils at neutral, and films at alkaline pH—and co-assemble it with alpha-hydroxy acids (AHAs) to lock it into skin-permeable nanoparticles, forming supramolecular co-assemblies (SCAs). SCAs enhanced intradermal peptide retention by 5 fold by loosening lipid chain packing without disrupting barrier integrity. Upon penetration, SCAs underwent pH-triggered disassembly-reassembly, forming branched biomimetic topologies. These supramolecular structures enabled whole-cell cytosolic delivery, upregulated proliferation and growth factor signaling, suppressed TRPV1-mediated inflammation, promoted ordered ECM & DEJ regeneration in ex vivo human skin, and reduced erythema while improving barrier function in a 35-subject clinical trial. By integrating dynamic morphological programming with bioactivity, this strategy of morphological transition after supramolecular delivery offers new research directions for the future development of transdermal delivery.
- Open Access
- 8 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Supramolecular janus eutectic engineered from panthenol and bisabolol overcomes transdermal delivery paradoxes
Conventional transdermal delivery systems are constrained by inherent trade-offs among penetration efficiency, bioactive potency, and skin biocompatibility. To overcome these limitations, here we show a supramolecular Janus eutectic engineered from D-panthenol and α-(-)-bisabolol (SPB). This carrier-free system effectively integrates autonomous permeation with multimodal therapeutic functions. SPB demonstrates synergistic enhancement of panthenol transdermal delivery while markedly improving the biocompatibility of bisabolol, alongside multiplex anti-irritation and pro-repair efficacy—a combination unattainable by its individual components or physical mixtures. Mechanistic investigations indicate that the supramolecular architecture modulates the active transport pathway and antagonizes the TRPV1 receptor. This work provides a practical strategy for designing biofunctional materials that intrinsically unify delivery, efficacy, and safety.
- 8 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSupramolecular janus eutectic engineered from panthenol and bisabolol overcomes transdermal delivery paradoxes
Conventional transdermal delivery systems are constrained by inherent trade-offs among penetration efficiency, bioactive potency, and skin biocompatibility. To overcome these limitations, here we show a supramolecular Janus eutectic engineered from D-panthenol and α-(-)-bisabolol (SPB). This carrier-free system effectively integrates autonomous permeation with multimodal therapeutic functions. SPB demonstrates synergistic enhancement of panthenol transdermal delivery while markedly improving the biocompatibility of bisabolol, alongside multiplex anti-irritation and pro-repair efficacy—a combination unattainable by its individual components or physical mixtures. Mechanistic investigations indicate that the supramolecular architecture modulates the active transport pathway and antagonizes the TRPV1 receptor. This work provides a practical strategy for designing biofunctional materials that intrinsically unify delivery, efficacy, and safety.
- 29 January 2026
- Published by S. Karger AG in Skin Pharmacology and Physiology
- Vol. 39 (2) , 47-57
A Supramolecular Salicylic Acid-Betaine with Superior Epidermal Benefits and Better Tolerance: In vitro Proof of Concept Studies
Introduction: Recent progress in supramolecule research has led to a surge in its application in cosmetic products. However, comprehensive investigation of the potential benefits, especially differentiating biological activities and associating that with physical-chemical properties, remains to be established. The current study aimed to investigate the supramolecular salicylic acid-betaine (Supra-SA-B) compared to its physical mixture (SA+B) for effects on epidermal homeostasis and topical insult potential. Methods: The structure of supra-SA-B and SA+B was characterized by a powder X-ray diffractometer. Skin tolerance was evaluated by applying SA, Supra-SA-B, and SA+B to human keratinocytes or SkinEthic™ reconstructed human epidermis (RHE) models. Inflammatory cytokines were assessed by Luminex assay. Histological morphology was evaluated by hematoxylin-eosin staining, with aquaporin-3 (AQP3) and Ki67 measured by immunofluorescence. RNA sequencing characterized overall biological response. Results: Characteristic peaks remained the same for Supra-SA-B after freeze-drying verified that their crystalline structures were retained in the current solution. Supra-SA-B treated groups demonstrated significantly higher viabilities compared to SA or SA+B. With 18-h of treatment, Supra-SA-B treated group released fewer cytokines. In addition, Supra-SA-B demonstrated a better hydration effect with increased AQP3 expression and more organized epidermal structure. Consistent result was observed in the RNA transcriptomic profiles of RHE models. Supra-SA-B did not induce major transcriptome drift as compared to SA or SA+B, with less evident negative impact on loricrin, and late cornified envelope gene expression. Hyaluronic acid synthase boosting was maintained. Conclusion: Supra-SA-B ameliorated skin tolerance risk for SA, enhanced hydration with less insult on barrier functions, suggesting promising potential for cosmetic application.
- 29 January 2026
- Published by S. Karger AG in Skin Pharmacology and Physiology
- Vol. 39 (2) , 47-57
A Supramolecular Salicylic Acid-Betaine with Superior Epidermal Benefits and Better Tolerance: In vitro Proof of Concept Studies
Introduction: Recent progress in supramolecule research has led to a surge in its application in cosmetic products. However, comprehensive investigation of the potential benefits, especially differentiating biological activities and associating that with physical-chemical properties, remains to be established. The current study aimed to investigate the supramolecular salicylic acid-betaine (Supra-SA-B) compared to its physical mixture (SA+B) for effects on epidermal homeostasis and topical insult potential. Methods: The structure of supra-SA-B and SA+B was characterized by a powder X-ray diffractometer. Skin tolerance was evaluated by applying SA, Supra-SA-B, and SA+B to human keratinocytes or SkinEthic™ reconstructed human epidermis (RHE) models. Inflammatory cytokines were assessed by Luminex assay. Histological morphology was evaluated by hematoxylin-eosin staining, with aquaporin-3 (AQP3) and Ki67 measured by immunofluorescence. RNA sequencing characterized overall biological response. Results: Characteristic peaks remained the same for Supra-SA-B after freeze-drying verified that their crystalline structures were retained in the current solution. Supra-SA-B treated groups demonstrated significantly higher viabilities compared to SA or SA+B. With 18-h of treatment, Supra-SA-B treated group released fewer cytokines. In addition, Supra-SA-B demonstrated a better hydration effect with increased AQP3 expression and more organized epidermal structure. Consistent result was observed in the RNA transcriptomic profiles of RHE models. Supra-SA-B did not induce major transcriptome drift as compared to SA or SA+B, with less evident negative impact on loricrin, and late cornified envelope gene expression. Hyaluronic acid synthase boosting was maintained. Conclusion: Supra-SA-B ameliorated skin tolerance risk for SA, enhanced hydration with less insult on barrier functions, suggesting promising potential for cosmetic application.
- Open Access
- 12 December 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (12) , e70592
In Vitro Bioactivity of a Recombinant Human Collagen Peptide in a Filler Biomimetic Skin Model
Background: Recombinant human collagen peptides (rhCol peptides) have demonstrated considerable promise in various biomedical applications, including wound healing, dermatological treatments, aesthetic procedures, cosmetic formulations, and personal healthcare. Recently, their incorporation as a bioactive component in dermal filler products has gained significant attraction within the aesthetic and cosmetic fields. Aims: To elucidate the beneficial bio‐efficacy of rhCol peptides as a dermal filler, underlying mechanisms from both the cell and tissue levels were explored. Methods: The stimulatory effect of rhCol peptides on extracellular matrix (ECM) production was confirmed in 2D human fibroblast cultures at mRNA levels. Subsequently, its impact on skin rejuvenation was illustrated, utilizing a novel, in‐house developed 3D in vitro filler biomimetic skin model, tissue morphology, epidermal proliferation and differentiation, as well as dermal ECM deposition were investigated. Transcriptomic analysis further offered an in‐depth view of molecular pathways underlying the phenotypical change observed at cellular and tissue levels. Results: In the 2D cell model, matrix remodeling–related genes such as Collagen type I and III, Elastin, Fibrillin 1, Hyaluronic acid synthases 1, 2, and 3 were significantly upregulated upon treatment with rhCol III peptides. Its direct binding to the dermal scaffold was confirmed within a novel filler biomimetic in vitro skin model, providing compelling evidence of their beneficial effects on both epidermal and dermal compartments, embodied in improved epidermis regeneration (Ki67, COL17A1) and dermis remodeling (FBN1 and glycosaminoglycans). Furthermore, transcriptomic analysis provided valuable insights into the potential mechanisms of downregulated inflammation, senescence and apoptosis; upregulated integrin binding; and extracellular matrix formation resulted from the binding of rhCol III peptides to the dermal scaffold. Conclusions: These findings collectively support the pro‐ECM potential of such rhCol III peptides as a promising biomaterial for dermal filler, as well as potential cosmetic applications. Limited by the gap between in vitro mimetic model and real injection, further clinical trials should be taken to reconfirm the potential benefits.
- 12 December 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (12) , e70592
Open AccessIn Vitro Bioactivity of a Recombinant Human Collagen Peptide in a Filler Biomimetic Skin Model
Background: Recombinant human collagen peptides (rhCol peptides) have demonstrated considerable promise in various biomedical applications, including wound healing, dermatological treatments, aesthetic procedures, cosmetic formulations, and personal healthcare. Recently, their incorporation as a bioactive component in dermal filler products has gained significant attraction within the aesthetic and cosmetic fields. Aims: To elucidate the beneficial bio‐efficacy of rhCol peptides as a dermal filler, underlying mechanisms from both the cell and tissue levels were explored. Methods: The stimulatory effect of rhCol peptides on extracellular matrix (ECM) production was confirmed in 2D human fibroblast cultures at mRNA levels. Subsequently, its impact on skin rejuvenation was illustrated, utilizing a novel, in‐house developed 3D in vitro filler biomimetic skin model, tissue morphology, epidermal proliferation and differentiation, as well as dermal ECM deposition were investigated. Transcriptomic analysis further offered an in‐depth view of molecular pathways underlying the phenotypical change observed at cellular and tissue levels. Results: In the 2D cell model, matrix remodeling–related genes such as Collagen type I and III, Elastin, Fibrillin 1, Hyaluronic acid synthases 1, 2, and 3 were significantly upregulated upon treatment with rhCol III peptides. Its direct binding to the dermal scaffold was confirmed within a novel filler biomimetic in vitro skin model, providing compelling evidence of their beneficial effects on both epidermal and dermal compartments, embodied in improved epidermis regeneration (Ki67, COL17A1) and dermis remodeling (FBN1 and glycosaminoglycans). Furthermore, transcriptomic analysis provided valuable insights into the potential mechanisms of downregulated inflammation, senescence and apoptosis; upregulated integrin binding; and extracellular matrix formation resulted from the binding of rhCol III peptides to the dermal scaffold. Conclusions: These findings collectively support the pro‐ECM potential of such rhCol III peptides as a promising biomaterial for dermal filler, as well as potential cosmetic applications. Limited by the gap between in vitro mimetic model and real injection, further clinical trials should be taken to reconfirm the potential benefits.
- 1 August 2022
- Published by Wiley in Phytotherapy Research
- Vol. 36 (12) , 4295-4298
High‐quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID‐19
Traditional Chinese medicine (TCM) has been employed as complementary medication against COVID‐19 in China since 2020. Two years since then, TCM, with Lianhua Qingwen (LHQW) as an example, has been included in every version of official clinical protocol guidelines. Recently, LHQW is even distributed to general public at risk but not yet infected. Such common application and widely claimed positive outcome among mild to moderate patients were accompanied by a number of published studies on antiviral, antiinflammatory, and immune modulatory potential using either in vitro or animal models. However, aside from retrospective understanding and open‐labeled clinical trials with relatively small subject size, major gap in conclusive proof for efficacy and safety remains due to the lack of double‐blind placebo‐controlled studies and comprehensive pharmacodynamic and kinetic investigations. This is also supported by a recent WHO expert meeting on this subject, which acknowledged the potential benefits of TCM in mild–moderate cases, while recommended more rigorous studies to further understand effect size, application implications, and outcome determinants. Therefore, there is an urgent need to address the exact role TCM like LHQW could play in COVID‐19 management from translational evidence‐based perspective. High‐quality clinical trials, pharmacological studies, and real‐world data from recent outbreak are recommended.
- 1 August 2022
- Published by Wiley in Phytotherapy Research
- Vol. 36 (12) , 4295-4298
High‐quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID‐19
Traditional Chinese medicine (TCM) has been employed as complementary medication against COVID‐19 in China since 2020. Two years since then, TCM, with Lianhua Qingwen (LHQW) as an example, has been included in every version of official clinical protocol guidelines. Recently, LHQW is even distributed to general public at risk but not yet infected. Such common application and widely claimed positive outcome among mild to moderate patients were accompanied by a number of published studies on antiviral, antiinflammatory, and immune modulatory potential using either in vitro or animal models. However, aside from retrospective understanding and open‐labeled clinical trials with relatively small subject size, major gap in conclusive proof for efficacy and safety remains due to the lack of double‐blind placebo‐controlled studies and comprehensive pharmacodynamic and kinetic investigations. This is also supported by a recent WHO expert meeting on this subject, which acknowledged the potential benefits of TCM in mild–moderate cases, while recommended more rigorous studies to further understand effect size, application implications, and outcome determinants. Therefore, there is an urgent need to address the exact role TCM like LHQW could play in COVID‐19 management from translational evidence‐based perspective. High‐quality clinical trials, pharmacological studies, and real‐world data from recent outbreak are recommended.
- Open Access
- 30 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 160946-160957
A Personalized Bayesian Approach for Early Intervention in Gestational Weight Gain Management Toward Pregnancy Care
Pre-pregnancy body mass index and weight gain management are associated with pregnancy outcomes in expecting women. Poor gestational weight gain (GWG) management could increase the risk of adverse complications. These risks can be alleviated by lifestyle-based interventions if an undesired GWG trend is detected early on in the pregnancy. Current literature lacks analysis of gestational weight gain data and tracking the pregnancy over time. In this work, we collected longitudinal gestational weight gain data from women during their pregnancy and model their weight measurements to predict the end-of-pregnancy weight gain and classify it in accordance with the medically recommended guidelines. The measurement frequency of the weights is often very variable such that segments of data can be missing and the need to predict early utilising few data points complicates data modelling. We propose a Bayesian approach to forecast weight gain while effectively dealing with the limited data availability for early prediction. We validate on diverse populations from Europe and China. We show that utilising individual’s data only up to mid-way through the pregnancy, our approach produces mean absolute errors of 2.45 kgs and 2.82 kgs in forecasting end-of-pregnancy weight gain on these populations respectively, whereas the best of state-of-the-art yields 8.17 and 6.60 kgs on respective populations. The proposed method can serve as a tool to keep track of an individual’s pregnancy and achieve GWG goals, thus supporting the prevention of excessive or insufficient weight gain during pregnancy.
- 30 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 9, 160946-160957
Open AccessA Personalized Bayesian Approach for Early Intervention in Gestational Weight Gain Management Toward Pregnancy Care
Pre-pregnancy body mass index and weight gain management are associated with pregnancy outcomes in expecting women. Poor gestational weight gain (GWG) management could increase the risk of adverse complications. These risks can be alleviated by lifestyle-based interventions if an undesired GWG trend is detected early on in the pregnancy. Current literature lacks analysis of gestational weight gain data and tracking the pregnancy over time. In this work, we collected longitudinal gestational weight gain data from women during their pregnancy and model their weight measurements to predict the end-of-pregnancy weight gain and classify it in accordance with the medically recommended guidelines. The measurement frequency of the weights is often very variable such that segments of data can be missing and the need to predict early utilising few data points complicates data modelling. We propose a Bayesian approach to forecast weight gain while effectively dealing with the limited data availability for early prediction. We validate on diverse populations from Europe and China. We show that utilising individual’s data only up to mid-way through the pregnancy, our approach produces mean absolute errors of 2.45 kgs and 2.82 kgs in forecasting end-of-pregnancy weight gain on these populations respectively, whereas the best of state-of-the-art yields 8.17 and 6.60 kgs on respective populations. The proposed method can serve as a tool to keep track of an individual’s pregnancy and achieve GWG goals, thus supporting the prevention of excessive or insufficient weight gain during pregnancy.
- 28 June 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (2) , 261-269
Protective effects of dietary fish‐oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: a pilot randomized, double‐blind, placebo‐controlled trial*
SummaryBackground. Exposure to fine particulate matter (with an aerodynamic diameter ≤ 2·5 μm, PM2·5) air pollution has been associated with skin‐related diseas
- 28 June 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (2) , 261-269
Protective effects of dietary fish‐oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: a pilot randomized, double‐blind, placebo‐controlled trial*
SummaryBackground. Exposure to fine particulate matter (with an aerodynamic diameter ≤ 2·5 μm, PM2·5) air pollution has been associated with skin‐related diseas
- 4 November 2019
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (7) , 1751-1759
Traffic‐derived air pollution compromises skin barrier function and stratum corneum redox status: A population study
Background Since air pollution is only one of many environmental stressors that can affect skin, it has been challenging to identify skin appearance or functional features profoundly affected by chronic exposure to traffic‐derived air pollution. Aims The current population study focused on taxi drivers working in urban and rural areas in order to take advantage of difference in occupational exposure. Methods The skin conditions of 100 middle‐aged male taxi drivers from urban Shanghai and 66 from rural Chongming were measured with facial tape strips were collected for biomarker analyses. Results Trans‐epidermal water loss (TEWL) values before and after tape stripping were considerably higher in urban taxi drivers from Shanghai. Contrary to previous studies, there was no apparent detrimental effect on skin wrinkle or pigmentation from traffic pollution, which might be attributed to the higher than general public level of photo‐exposure in this population. At the same time, pollution exposure especially the heavy traffic pollution exposure was found to associate with lower stratum corneum trypsin‐like enzyme activity (SCTE), reduced catalase activity and total antioxidant capacity (TAOC) in tape strips. Conclusion The evidence suggests that traffic‐derived air pollution could deteriorate skin's physical and antioxidant barrier, whereas factors like photo‐exposure can be overwhelming against appearance aging. Therefore, in addition to photoprotection, skin barrier care should be considered for people with high air pollution exposure.
- 4 November 2019
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 19 (7) , 1751-1759
Traffic‐derived air pollution compromises skin barrier function and stratum corneum redox status: A population study
Background Since air pollution is only one of many environmental stressors that can affect skin, it has been challenging to identify skin appearance or functional features profoundly affected by chronic exposure to traffic‐derived air pollution. Aims The current population study focused on taxi drivers working in urban and rural areas in order to take advantage of difference in occupational exposure. Methods The skin conditions of 100 middle‐aged male taxi drivers from urban Shanghai and 66 from rural Chongming were measured with facial tape strips were collected for biomarker analyses. Results Trans‐epidermal water loss (TEWL) values before and after tape stripping were considerably higher in urban taxi drivers from Shanghai. Contrary to previous studies, there was no apparent detrimental effect on skin wrinkle or pigmentation from traffic pollution, which might be attributed to the higher than general public level of photo‐exposure in this population. At the same time, pollution exposure especially the heavy traffic pollution exposure was found to associate with lower stratum corneum trypsin‐like enzyme activity (SCTE), reduced catalase activity and total antioxidant capacity (TAOC) in tape strips. Conclusion The evidence suggests that traffic‐derived air pollution could deteriorate skin's physical and antioxidant barrier, whereas factors like photo‐exposure can be overwhelming against appearance aging. Therefore, in addition to photoprotection, skin barrier care should be considered for people with high air pollution exposure.